alpha-methyl-m-tyrosine has been researched along with Arrhythmias, Cardiac in 1 studies
alpha-methyl-m-tyrosine: RN given refers to cpd without stereoisomeric designation; structure in Merck Index, 9th ed, #6004
Arrhythmias, Cardiac: Any disturbances of the normal rhythmic beating of the heart or MYOCARDIAL CONTRACTION. Cardiac arrhythmias can be classified by the abnormalities in HEART RATE, disorders of electrical impulse generation, or impulse conduction.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abrahamsson, T | 1 |
Almgren, O | 1 |
Carlsson, L | 1 |
Svensson, L | 1 |
1 other study available for alpha-methyl-m-tyrosine and Arrhythmias, Cardiac
Article | Year |
---|---|
Antiarrhythmic effect of reducing myocardial noradrenaline stores with alpha-methyl-meta-tyrosine.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Furosemide; Hemodynamics; Male; Methyltyrosin | 1985 |